From Team Pappas <[email protected]>
Subject Helping over 31,000 seniors in NH save on their prescriptions.
Date September 6, 2023 9:00 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
No one should have to choose between their health and putting food on the table, team.

But for too long, big drug companies have raked in record profits while hard-working Americans, including many Granite Staters, have struggled to afford life-saving medications.

That's why Chris was proud to help pass the Inflation Reduction Act last year which allows Medicare to negotiate prices and helps lower drug costs for thousands of seniors right here in New Hampshire. Last week the White House announced the first ten drugs subject to Medicare price negotiations. This action will help over 31,000 Granite State seniors save on their prescriptions.

But Chris knows that our work isn't done. Conservative groups and big pharmaceutical companies are suing to prevent these crucial drug price negotiations.

As long as Chris is in Congress, he'll stand up against big pharma and continue to fight tooth and nail for affordable healthcare for all Americans. But he can't do it alone.

Will you chip in $5, $25, or whatever you can to help Chris continue fighting for lower drug prices in the House? >> [link removed]

Thank you,

Team Pappas

Chris Pappas is running for reelection in the "swingiest district in the nation." It's going to take a grassroots movement to win. Help fuel his campaign by chipping in today.

DONATE >> [link removed]


Paid for by Chris Pappas for Congress
Chris Pappas for Congress
PO Box 313
Manchester, NH 03105
United States
[link removed]

We believe that emails are a crucial way for our campaign to stay in touch with supporters like you. However, if you believe you received this message in error or wish to no longer receive email from us, you can click here to unsubscribe: [link removed] .
Screenshot of the email generated on import

Message Analysis